BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 10422553)

  • 41. [Hematochromatosis and diabetes].
    Thielen V; Paquot N; Scheen AJ
    Rev Med Liege; 2004 Jan; 59(1):29-31. PubMed ID: 15035540
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Review article: the modern diagnosis and management of haemochromatosis.
    Adams PC
    Aliment Pharmacol Ther; 2006 Jun; 23(12):1681-91. PubMed ID: 16817911
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnosis and management of hereditary haemochromatosis.
    van Bokhoven MA; van Deursen CT; Swinkels DW
    BMJ; 2011 Jan; 342():c7251. PubMed ID: 21248018
    [No Abstract]   [Full Text] [Related]  

  • 44. Rusfertide for the treatment of iron overload in HFE-related haemochromatosis: an open-label, multicentre, proof-of-concept phase 2 trial.
    Kowdley KV; Modi NB; Peltekian K; Vierling JM; Ferris C; Valone FH; Gupta S
    Lancet Gastroenterol Hepatol; 2023 Dec; 8(12):1118-1128. PubMed ID: 37863080
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Screening for genetic haemochromatosis in blood samples with raised alanine aminotransferase.
    Bhavnani M; Lloyd D; Bhattacharyya A; Marples J; Elton P; Worwood M
    Gut; 2000 May; 46(5):707-10. PubMed ID: 10764716
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Iron status markers in hereditary haemochromatosis: distinction between individuals being homozygous and heterozygous for the haemochromatosis allele.
    Milman N
    Eur J Haematol; 1991 Oct; 47(4):292-8. PubMed ID: 1954989
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Multifocal nodular fatty infiltration of the liver associated with porphyria and haemochromatosis].
    Daberkow U; Dörffel Y; Schmidt H; Scholze J
    Dtsch Med Wochenschr; 2004 Mar; 129(12):617-20. PubMed ID: 15011131
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Genetic iron overloads and hepatic insulin-resistance iron overload syndrome: an update].
    Ruivard M
    Rev Med Interne; 2009 Jan; 30(1):35-42. PubMed ID: 18584923
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Modern diagnosis and treatment methods in hereditary hemochromatosis].
    Loginov AS; Tokarev IuN; Settarova DA; Sukhareva GV
    Ter Arkh; 1988; 60(10):117-21. PubMed ID: 3222734
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Flu-like infection and liver disease after a stay in the tropics].
    Schneider M; Gehrke S; Nothdurft HD; Stremmel W
    Dtsch Med Wochenschr; 1999 Oct; 124(39):1127-30. PubMed ID: 10544683
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hereditary hemochromatosis. Detecting and correcting iron overload.
    Olynyk JK; Bacon BR
    Postgrad Med; 1994 Oct; 96(5):151-8, 161, 165. PubMed ID: 7937414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Screening primary care patients for hereditary hemochromatosis with transferrin saturation and serum ferritin level: systematic review for the American College of Physicians.
    Schmitt B; Golub RM; Green R
    Ann Intern Med; 2005 Oct; 143(7):522-36. PubMed ID: 16204165
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Erythrocyte ferritin content in idiopathic haemochromatosis and alcoholic liver disease with iron overload.
    Van Der Weyden MB; Fong H; Salem HH; Batey RG; Dudley FJ
    Br Med J (Clin Res Ed); 1983 Mar; 286(6367):752-4. PubMed ID: 6402233
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hereditary haemochromatosis.
    Mohamed M; Phillips J
    BMJ; 2016 Jun; 353():i3128. PubMed ID: 27365180
    [No Abstract]   [Full Text] [Related]  

  • 55. Screening for hereditary haemochromatosis within families and beyond.
    McCune CA; Ravine D; Worwood M; Jackson HA; Evans HM; Hutton D
    Lancet; 2003 Dec; 362(9399):1897-8. PubMed ID: 14667749
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hereditary haemochromatosis in Denmark 1950-1985. Clinical, biochemical and histological features in 179 patients and 13 preclinical cases.
    Milman N
    Dan Med Bull; 1991 Aug; 38(4):385-93. PubMed ID: 1914539
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Recommendations of EASL clinical practice guidelines on haemochromatosis].
    Tang S; Zheng SJ; Duan ZP
    Zhonghua Gan Zang Bing Za Zhi; 2022 Sep; 30(9):934-938. PubMed ID: 36299186
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Idiopathic hemochromatosis--diagnosis and therapy].
    Schmidt U; Preu E; Tuschy U; Senf L; Herre K
    Z Gesamte Inn Med; 1984 Apr; 39(8):152-60. PubMed ID: 6730591
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Practical management of HFE hemochromatosis].
    Brissot P; Bismuth M; Peynaud-Debayle E; de Bels F
    Rev Prat; 2006 Dec; 56(19):2123-9. PubMed ID: 17416049
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Idiopathic hemochromatosis: current problems in diagnosis and therapy].
    Fehr J
    Schweiz Med Wochenschr; 1979 Apr; 109(17):633-9. PubMed ID: 441715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.